From: Regulation of reverse cholesterol transport - a comprehensive appraisal of available animal studies
Factor investigated | Intervention | Animal model | Type of macrophages used | Effect on RCT | Ref |
---|---|---|---|---|---|
Macrophage | Â | Â | Â | Â | Â |
ApoE | ApoE knockout macrophages | Wild-type mice | Peritoneal | ↓ | [24] |
CE hydrolysis | Human nCEH transgenic macrophages | LDLr knockout mice | Peritoneal | ↑ | [29] |
ABCA1 | ABCA1 knockout macrophages | Wild-type mice | Bone marrow | ↓ | |
ABCG1 | ABCG1 overexpression in macrophages | Wild-type mice | J774 | ↑ | [31] |
 | ABCG1 knockdown in macrophages | Wild-type mice | J774 | ↓ | [31] |
 | ABCG1 knockout macrophages | Wild-type mice | Bone marrow | ↓ | [31] |
ABCA1/ABCG1 | ABCA1/ABCG1 double knockdown in macrophages | Wild-type mice | J774 | ↓ | [31] |
 | ABCA1/ABCG1 double knockout macrophages | Wild-type mice | Bone marrow | ↓ | [32] |
SR-BI | SR-BI knockout macrophages | Wild-type mice | Bone marrow | = | [31] |
 | SR-BI knockout macrophages | Wild-type mice | Bone marrow | = | [33] |
ABCA1/SR-BI | ABCA1/SR-BI double knockout macrophages | Wild-type mice | Bone marrow | ↓ | [33] |
PLTP | PLTP knockout macrophages | Wild-type mice | Peritoneal | = | [34] |
CETP | CETP overexpression in macrophages | Wild-type mice | RAW 267.4 | = | [35] |
 | CETP overexpression in macrophages | Wild-type mice | Peritoneal | = | [36] |
15(S)-lipoxygenase-1 | Human 15(S)-lipoxygenase-1 overexpression in macrophages | Wild-type mice | RAW 267.4 | ↑ | [37] |
Myeloid differentiation primary response protein 88 | MyD88 knockout macrophages | Wild-type | Peritoneal | ↓ | [38] |
Transport through the plasma compartment | Â | Â | Â | Â | Â |
ApoA-I | Adenoviral overexpression human apoA-I | Wild-type mice | J774 | ↑ | [18] |
 | ApoA-I knockout | LDLr/apobec double knockout mice | J774 | ↓ | [39] |
 | Adenoviral overexpression mouse or human apoA-I (wild-type or apoA-I Milano) | ApoA-I knockout mice | J774 | ↑ | |
 | Ro 11-1464 | Human apoA-I transgenic mice | J774 | ↑ | [42] |
ApoA-I tertiary structural domain | AAV overexpression domain-swap variants of human and mouse apoA-I | ApoA-I knockout mice | J774 | ↑ | [40] |
ApoA-I Milano versus wild-type apoA-I | AAV overexpression | ApoA-I knockout mice | J774 | = | [41] |
ApoA-I mimetic peptides | D-4 F | ApoE knockout mice | J774 | ↑ | [43] |
 | 5A | Wild-type mice | RAW 264.7 | ↑ | [17] |
 | ATI-5261 | ApoE knockout mice | J774 | ↑ | [44] |
HDL particle formation | ABCA1 knockout | ABCA1 knockout mice | Endogenous | ↓ | [45] |
 | ABCA1 knockout | ABCA1 knockout mice | Peritoneal | ↓ | [33] |
 | Probucol | Wild-type mice | J774 | = | [46] |
 | Probucol | SR-BI knockout mice | J774 | ↑ | [46] |
LCAT | AAV overexpression human LCAT | Human apoA-I transgenic mice | J774 | ↓ | [47] |
 | AAV overexpression human LCAT | Human apoA-I transgenic mice overexpressing SR-BI | J774 | = | [47] |
 | AAV overexpression human LCAT | Human apoA-I transgenic mice overexpressing human CETP | J774 | = | [47] |
 | LCAT knockout | LCAT knockout mice | J774 | ↓ | [47] |
Hepatic lipase | HL knockout | HL knockout mice | J774 | = | [48] |
Endothelial lipase | EL knockout | EL knockout mice | J774 | = | [48] |
 | Inhibition hepatic proprotein convertases | Wild-type mice | J774 | ↓ | [49] |
Hepatic lipase/endothelial lipase | HL/EL double knockout | HL/EL double knockout mice | J774 | = | [48] |
PLTP | PLTP overexpression | Human PLTP transgenic mice | Peritoneal | ↓ | [34] |
CETP | Adenoviral CETP overexpression | Wild-type mice | RAW 264.7 | ↑ | [35] |
 | AAV overexpression human CETP | Apobec knockout mice | J774 | ↑ | [50] |
 | AAV overexpression human CETP | LDLr/apobec double knockout mice | J774 | = | [50] |
 | AAV overexpression human CETP | SR-BI knockout mice | J774 | ↑ | [50] |
 | CETP overexpression | Cynomolgus monkey CETP transgenic mice | P388D1 or peritoneal | = | [36] |
 | CETP overexpression | Human CETP transgenic mice | Bone marrow | = | [51] |
CETP inhibition | Torcetrapib | Hamsters | J774 | ↑ | [35] |
 | Torcetrapib | Hamsters | Peritoneal | ↑ | [52] |
 | Torcetrapib | Human CETP/human apoB100 transgenic mice | J774 | ↑ | [53] |
 | Anacetrapib | Hamsters | Peritoneal | = | [52] |
 | Anacetrapib | Hamsters | J774 | ↑ | [54] |
 | Dalcetrapib | Hamsters | Peritoneal | ↑ | [52] |
ApoA-II | Overexpression human apoA-II | Human apoA-II transgenic mice | P388D1 | ↑ or = | [55] |
ApoF | AAV overexpression mouse apoF | Wild-type mice | J774 | = | [56] |
Uptake by the liver | Â | Â | Â | Â | Â |
Selective uptake | Adenoviral overexpression SR-BI | Wild-type mice | J774 | ↑ | [57] |
 | Adenoviral overexpression SR-BI | Human apoA-I transgenic mice | J774 | ↑ | [57] |
 | SR-BI knockout | SR-BI knockout mice | J774 | ↓ | [57] |
 | SR-BI knockout | SR-BI knockout mice | Peritoneal | ↓ | [33] |
 | SR-BI knockout | SR-BI knockout mice | Bone marrow | ↓ | [51] |
 | Transgenic CETP overexpression | SR-BI knockout mice | Bone marrow | = | [51] |
 | Liver-specific SR-BI knockout | SR-BI conditional knockout mice | Bone marrow | ↓ | [51] |
 | Transgenic CETP overexpression | SR-BI conditional knockout mice | Bone marrow | = | [51] |
Holoparticle uptake | P2Y13 knockout | P2Y13 knockout mice | Peritoneal | ↓ | [58] |
Type 1 diabetes mellitus | Alloxan | Wild-type mice | Peritoneal | ↓ | [59] |
 | Streptozotocin | Wild-type mice | J774 | ↓ | [60] |
 | Streptozotocin | Hp2-2 mice | J774 | ↓ | [60] |
Excretion into the intestine | Â | Â | Â | Â | Â |
CE hydrolysis liver | Adenoviral overexpression human nCEH | Wild-type mice | J774 | ↑ | [61] |
 | Carboxyl ester lipase knockout | Carboxyl ester lipase knockout mice | J774 | ↑ | [62] |
ABCG5/ABCG8 | ABCG5/ABCG8 double knockout | ABCG5/ABCG8 double knockout mice | P388D1 | = | [63] |
Biliary sterol secretion | Bile duct ligation | Wild-type mice | Peritoneal | ↓ | [64] |
 | Surgical biliary diversion | Wild-type mice | J774 | = | [65] |
 | Transgenic overexpression NPC1L1 in the liver | Liver-specific human NPC1L1 transgenic mice | J774 | = | [65] |
MDR2 | MDR2 knockout | MDR2 knockout mice | Peritoneal | ↓ | [64] |
Excretion from the body | Â | Â | Â | Â | Â |
NPC1L1 intestine | Ezetimibe | Wild-type mice | J774 | ↑ | [66] |
 | Ezetimibe | Wild-type mice | RAW 264.7 | ↑ | [67] |
Cholesterol absorption intestine | Congenic 14DKK interval | 14DKK congenic mice | RAW 264.7 | ↑ | [67] |
 | Congenic 14DKK interval | 14DKK apoE knockout congenic mice | Bone marrow | ↑ | [68] |
Inflammation | Â | Â | Â | Â | Â |
Acute inflammatory response | LPS | Wild-type mice | Peritoneal | ↓ | [69] |
 | LPS | Wild-type mice | J774 | ↓ | [70] |
 | Zymosan | Wild-type mice | RAW 264.7 | ↓ | [71] |
Human group IIA secretory phospholipase A2 | Overexpression human group IIA secretory phospholipase A2 | Human group IIA secretory phospholipase A2 transgenic mice | Peritoneal | = | [69] |
Serum amyloid A | Adenoviral overexpression human serum amyloid A | Wild-type mice | Peritoneal | = | [69] |
 | Adenoviral overexpression mouse serum amyloid A | Wild-type mice | Peritoneal | ↓ | [69] |
Myeloperoxidase | Human myeloperoxidase | Wild-type mice | Peritoneal | ↓ | [69] |
Mast cell activation | Mast cell degranulating compound 48/80 | Wild-type mice treated with human apoA-I | J774 | ↓ | [72] |
Drugs | Â | Â | Â | Â | Â |
LXR agonist | GW3965 | Wild-type mice | J774 | ↑ | |
 | GW3965 | LDLr/apobec double knockout mice | J774 | ↑ | [73] |
 | GW3965 | ApoB/CETP double transgenic mice | J774 | ↑ | [73] |
 | T0901317 | Wild-type BALB/c mice | J774 | ↑ | [75] |
 | GW3965 | Hamsters | J774 | ↑ | [76] |
 | T0901317 | Wild-type mice | P388D1 | ↑ | [63] |
 | T0901317 | ABCG5/ABCG8 double knockout mice | P388D1 | = | [63] |
 | T0901317 | Wild-type FVB mice | Peritoneal | ↑ | [64] |
 | T0901317 | MDR2 knockout mice | Peritoneal | = | [64] |
 | GW3965 | LXR double knockout mice | J774 | = | [74] |
 | GW3965 | Wild-type mice | Bone marrow (wild-type and LXR double knockout) | = | [74] |
Intestine-specific LXR activation | Constitutively activated LXRα in the intestine | iVP16LXRα transgenic mice | J774 | ↑ | [77] |
Liver-specific LXR activation | Adenoviral overexpression constitutively active LXRα | Wild-type FVB mice | J774 | = | [77] |
Intestine-specific LXR agonist | GW6340 | Wild-type mice | J774 | ↑ | [74] |
PPARα agonist | GW7647 | Wild-type mice | J774 | ↑ | [78] |
 | GW7647 | Human apoA-I transgenic mice | J774 | ↑ | [78] |
 | GW7647 | LDLr/apobec double knockout mice | J774 | ↑ | [78] |
 | GW7647 | Human apoA-I transgenic mice | Bone marrow (PPARα knockout) | = | [78] |
 | GW7647 | Human apoA-I transgenic mice | Bone marrow (LXR double knockout) | = | [78] |
 | Fenofibrate | Human apoA-I transgenic mice | P388D1 | ↑ | [79] |
 | Gemfibrozil | Human apoA-I transgenic mice | P388D1 | = | [79] |
PPARδ agonist | GW0742 | Wild-type mice | J774 | ↑ | [66] |
PPARγ agonist | GW7845 | Wild-type mice | J774 | ↓ | [80] |
FXR agonist | GW4064 | Wild-type mice | J774 | ↑ | [81] |
 | GW4064 | SR-BI knockout mice | J774 | ↑ | [81] |
Liver-specific FXR activation | Adenoviral overexpression constitutively active FXR | Wild-type mice | J774 | ↑ | [81] |
miR-33 antagonism | Anti-miR33 oligonucleotide | LDLr knockout mice | Bone marrow | ↑ | [82] |
Liver-selective thyromimetic | T-0681 | Wild-type mice | J774 | ↑ | [83] |
 | T-0681 | CETP transgenic mice | J774 | = | [83] |
Sylfonylurea agent | Glibenclamide | Wild-type mice | RAW 264.7 | = | [84] |
 | Glimepiride | Wild-type mice | RAW 264.7 | = | [84] |
Anti-HIV drug | Nevirapine | Human apoA-I transgenic mice | J774 | = | [85] |
 | Efavirenz | Human apoA-I transgenic mice | J774 | ↑ | [85] |
Phosphodiesterase 3 inhibition | Cilostazol | Wild-type mice | RAW 264.7 | ↑ | [86] |
Proteasomal inhibition | Bortezomib | Wild-type mice | RAW 264.7 | ↑ | [87] |
Propolis extract | Ethanolic extract of propolis | Wild-type mice | RAW 264.7 | ↑ | [88] |
Dietary modifications | Â | Â | Â | Â | Â |
Dietary cholesterol | Cholesterol-enriched diet | Hamsters | Peritoneal | ↓ | [89] |
Dietary cholesterol and fat | Saturated fatty acid- and cholesterol-enriched diet | Wild-type mice | P388D1 | ↑ | [90] |
 | Saturated fatty acid-enriched diet | Wild-type mice | P388D1 | = | [90] |
Coffee | Coffee | Wild-type mice | RAW 264.7 | = | [91] |
 | Ferulic acid | Wild-type mice | RAW 264.7 | ↑ | [91] |
Fish oil | Fish oil | Wild-type mice | J774 | ↑ | [92] |
Exercise | Â | Â | Â | Â | Â |
Exercise | Voluntary wheel running | Wild-type mice | Peritoneal | = | [93] |
 | Monitored wheel running | Human CETP transgenic mice | J774 | ↑ | [94] |